Absolute 0 8 0 8 B-clinical_variable
neutrophil 9 19 9 19 I-clinical_variable
count 20 25 20 25 I-clinical_variable
> 26 27 26 27 O
= 27 28 27 28 O
1,500 29 34 29 34 B-lower_bound
/ 34 35 34 35 I-lower_bound
mcL 35 38 35 38 I-lower_bound

Aspartate 0 9 39 48 B-clinical_variable
aminotransferase 10 26 49 65 I-clinical_variable
( 27 28 66 67 I-clinical_variable
AST 28 31 67 70 I-clinical_variable
) 31 32 70 71 I-clinical_variable
( 33 34 72 73 I-clinical_variable
serum 34 39 73 78 I-clinical_variable
glutamic 40 48 79 87 I-clinical_variable
oxaloacetic 49 60 88 99 I-clinical_variable
transaminase 61 73 100 112 I-clinical_variable
[ 74 75 113 114 I-clinical_variable
SGOT])/alanine 75 89 114 128 I-clinical_variable
aminotransferase 90 106 129 145 I-clinical_variable
( 107 108 146 147 I-clinical_variable
ALT 108 111 147 150 I-clinical_variable
) 111 112 150 151 I-clinical_variable
( 113 114 152 153 I-clinical_variable
serum 114 119 153 158 I-clinical_variable
glutamate 120 129 159 168 I-clinical_variable
pyruvate 130 138 169 177 I-clinical_variable
transaminase 139 151 178 190 I-clinical_variable
[ 152 153 191 192 I-clinical_variable
SGPT 153 157 192 196 I-clinical_variable
] 157 158 196 197 I-clinical_variable
) 158 159 197 198 I-clinical_variable
= 160 161 199 200 O
< 161 162 200 201 O
2.5 163 166 202 205 B-upper_bound
x 167 168 206 207 I-upper_bound
institutional 169 182 208 221 I-upper_bound
upper 183 188 222 227 I-upper_bound
limit 189 194 228 233 I-upper_bound
of 195 197 234 236 I-upper_bound
normal 198 204 237 243 I-upper_bound

Carcinoma 0 9 244 253 B-cancer
of 10 12 254 256 O
the 13 16 257 260 O
neck 17 21 261 265 O
of 22 24 266 268 O
unknown 25 32 269 276 O
primary 33 40 277 284 O
site 41 45 285 289 O
origin 46 52 290 296 O
( 53 54 297 298 O
regardless 54 64 298 308 O
of 65 67 309 311 O
HPV 68 71 312 315 O
/ 71 72 315 316 O
p16 72 75 316 319 O
status 76 82 320 326 O
) 82 83 326 327 O

Clinical 0 8 328 336 B-clinical_variable
staged 9 15 337 343 I-clinical_variable
III 16 19 344 347 B-lower_bound
or 20 22 348 350 O
IV 23 25 351 353 B-upper_bound
HNSCC 26 31 354 359 B-cancer
that 32 36 360 364 O
is 37 39 365 367 O
not 40 43 368 371 O
amenable 44 52 372 380 O
to 53 55 381 383 O
surgical 56 64 384 392 B-treatment
resection 65 74 393 402 I-treatment

Creatinine 0 10 403 413 B-clinical_variable
within 11 17 414 420 O
normal 18 24 421 427 O
institutional 25 38 428 441 O
limits 39 45 442 448 O
OR 46 48 449 451 O
creatinine 49 59 452 462 B-clinical_variable
clearance 60 69 463 472 I-clinical_variable
> 70 71 473 474 O
= 71 72 474 475 O
60 73 75 476 478 B-lower_bound
mL 76 78 479 481 I-lower_bound
/ 78 79 481 482 I-lower_bound
min/1.73 79 87 482 490 I-lower_bound
m^2 88 91 491 494 I-lower_bound
for 92 95 495 498 O
patients 96 104 499 507 O
with 105 109 508 512 O
creatinine 110 120 513 523 B-clinical_variable
levels 121 127 524 530 I-clinical_variable
above 128 133 531 536 O
institutional 134 147 537 550 O
normal 148 154 551 557 O

Definitive 0 10 558 568 O
clinical 11 19 569 577 O
or 20 22 578 580 O
radiographic 23 35 581 593 O
evidence 36 44 594 602 O
of 45 47 603 605 O
distant 48 55 606 613 B-cancer
metastasis 56 66 614 624 I-cancer
or 67 69 625 627 O
adenopathy 70 80 628 638 B-chronic_disease
below 81 86 639 644 O
the 87 90 645 648 O
clavicles 91 100 649 658 O

Eastern 0 7 659 666 B-clinical_variable
Cooperative 8 19 667 678 I-clinical_variable
Oncology 20 28 679 687 I-clinical_variable
Group 29 34 688 693 I-clinical_variable
( 35 36 694 695 I-clinical_variable
ECOG 36 40 695 699 I-clinical_variable
) 40 41 699 700 I-clinical_variable
performance 42 53 701 712 I-clinical_variable
status 54 60 713 719 I-clinical_variable
= 61 62 720 721 O
< 62 63 721 722 O
2 64 65 723 724 B-upper_bound
( 66 67 725 726 O
Karnofsky 67 76 726 735 B-clinical_variable
> 77 78 736 737 O
= 78 79 737 738 O
60 80 82 739 741 B-lower_bound
% 82 83 741 742 I-lower_bound
) 83 84 742 743 O

HIV 0 3 744 747 B-chronic_disease
- 3 4 747 748 O
positive 4 12 748 756 O
patients 13 21 757 765 O
on 22 24 766 768 O
combination 25 36 769 780 B-treatment
antiretroviral 37 51 781 795 I-treatment
therapy 52 59 796 803 I-treatment
with 60 64 804 808 I-treatment
strong 65 71 809 815 I-treatment
inducers 72 80 816 824 I-treatment
or 81 83 825 827 O
inhibitors 84 94 828 838 B-treatment
of 95 97 839 841 I-treatment
CYP3A4 98 104 842 848 I-treatment

History 0 7 849 856 O
of 8 10 857 859 O
allergic 11 19 860 868 O
reactions 20 29 869 878 O
attributed 30 40 879 889 O
to 41 43 890 892 O
compounds 44 53 893 902 O
of 54 56 903 905 O
similar 57 64 906 913 O
chemical 65 73 914 922 O
or 74 76 923 925 O
biologic 77 85 926 934 O
composition 86 97 935 946 O
to 98 100 947 949 O
M6620 101 106 950 955 B-allergy_name
( 107 108 956 957 I-allergy_name
VX-970 108 114 957 963 I-allergy_name
) 114 115 963 964 I-allergy_name
or 116 118 965 967 O
cisplatin 119 128 968 977 B-allergy_name

Human 0 5 978 983 B-chronic_disease
immunodeficiency 6 22 984 1000 I-chronic_disease
virus 23 28 1001 1006 I-chronic_disease
( 29 30 1007 1008 I-chronic_disease
HIV)-positive 30 43 1008 1021 I-chronic_disease
patients 44 52 1022 1030 O
with 53 57 1031 1035 O
well 58 62 1036 1040 O
- 62 63 1040 1041 O
controlled 63 73 1041 1051 O
disease 74 81 1052 1059 O
, 81 82 1059 1060 O
as 83 85 1061 1063 O
determined 86 96 1064 1074 O
by 97 99 1075 1077 O
CD4 100 103 1078 1081 O
count 104 109 1082 1087 O
and 110 113 1088 1091 O
viral 114 119 1092 1097 O
load 120 124 1098 1102 O
, 124 125 1102 1103 O
who 126 129 1104 1107 O
are 130 133 1108 1111 O
on 134 136 1112 1114 O
antiretroviral 137 151 1115 1129 B-treatment
therapy 152 159 1130 1137 I-treatment
that 160 164 1138 1142 O
does 165 169 1143 1147 O
not 170 173 1148 1151 O
contain 174 181 1152 1159 O
a 182 183 1160 1161 O
strong 184 190 1162 1168 O
inducer 191 198 1169 1176 O
or 199 201 1177 1179 O
inhibitor 202 211 1180 1189 B-treatment
of 212 214 1190 1192 I-treatment
CYP3A4 215 221 1193 1199 I-treatment
are 222 225 1200 1203 O
allowed 226 233 1204 1211 O
on 234 236 1212 1214 O
trial 237 242 1215 1220 O

Leukocytes 0 10 1221 1231 B-clinical_variable
> 11 12 1232 1233 O
= 12 13 1233 1234 O
3,000 14 19 1235 1240 B-lower_bound
/ 19 20 1240 1241 I-lower_bound
mcL 20 23 1241 1244 I-lower_bound

Life 0 4 1245 1249 B-clinical_variable
expectancy 5 15 1250 1260 I-clinical_variable
of 16 18 1261 1263 O
greater 19 26 1264 1271 O
than 27 31 1272 1276 O
3 32 33 1277 1278 B-lower_bound
months 34 40 1279 1285 I-lower_bound

Myocardial 0 10 1286 1296 B-chronic_disease
infarction 11 21 1297 1307 I-chronic_disease
within 22 28 1308 1314 O
the 29 32 1315 1318 O
last 33 37 1319 1323 B-upper_bound
6 38 39 1324 1325 I-upper_bound
months 40 46 1326 1332 I-upper_bound

Ongoing 0 7 1333 1340 O
or 8 10 1341 1343 O
active 11 17 1344 1350 B-chronic_disease
infection 18 27 1351 1360 I-chronic_disease
requiring 28 37 1361 1370 O
intravenous 38 49 1371 1382 B-treatment
antibiotics 50 61 1383 1394 I-treatment
at 62 64 1395 1397 O
the 65 68 1398 1401 O
time 69 73 1402 1406 O
of 74 76 1407 1409 O
treatment 77 86 1410 1419 B-treatment
initiation 87 97 1420 1430 O

Patient 0 7 1431 1438 O
who 8 11 1439 1442 O
requires 12 20 1443 1451 O
live 21 25 1452 1456 B-treatment
vaccine 26 33 1457 1464 I-treatment
administration 34 48 1465 1479 O

Patients 0 8 1480 1488 O
must 9 13 1489 1493 O
have 14 18 1494 1498 O
histologically 19 33 1499 1513 O
or 34 36 1514 1516 O
cytologically 37 50 1517 1530 O
confirmed 51 60 1531 1540 O
head 61 65 1541 1545 B-cancer
and 66 69 1546 1549 I-cancer
neck 70 74 1550 1554 I-cancer
squamous 75 83 1555 1563 I-cancer
cell 84 88 1564 1568 I-cancer
cancer 89 95 1569 1575 I-cancer
( 96 97 1576 1577 I-cancer
HNSCC 97 102 1577 1582 I-cancer
) 102 103 1582 1583 I-cancer
including 104 113 1584 1593 O
paranasal 114 123 1594 1603 B-cancer
sinus 124 129 1604 1609 I-cancer
cancers 130 137 1610 1617 I-cancer

Patients 0 8 1618 1626 O
must 9 13 1627 1631 O
have 14 18 1632 1636 O
measurable 19 29 1637 1647 O
disease 30 37 1648 1655 O
, 37 38 1655 1656 O
defined 39 46 1657 1664 O
as 47 49 1665 1667 O
at 50 52 1668 1670 O
least 53 58 1671 1676 O
one 59 62 1677 1680 B-lower_bound
lesion 63 69 1681 1687 O
that 70 74 1688 1692 O
can 75 78 1693 1696 O
be 79 81 1697 1699 O
accurately 82 92 1700 1710 O
measured 93 101 1711 1719 O
in 102 104 1720 1722 O
at 105 107 1723 1725 O
least 108 113 1726 1731 O
one 114 117 1732 1735 O
dimension 118 127 1736 1745 O
( 128 129 1746 1747 O
longest 129 136 1747 1754 O
diameter 137 145 1755 1763 O
to 146 148 1764 1766 O
be 149 151 1767 1769 O
recorded 152 160 1770 1778 O
for 161 164 1779 1782 O
non 165 168 1783 1786 O
- 168 169 1786 1787 O
nodal 169 174 1787 1792 O
lesions 175 182 1793 1800 O
and 183 186 1801 1804 O
short 187 192 1805 1810 O
axis 193 197 1811 1815 O
for 198 201 1816 1819 O
nodal 202 207 1820 1825 O
lesions 208 215 1826 1833 O
) 215 216 1833 1834 O
as 217 219 1835 1837 O
> 220 221 1838 1839 O
= 221 222 1839 1840 O
20 223 225 1841 1843 B-lower_bound
mm 226 228 1844 1846 I-lower_bound
( 229 230 1847 1848 O
> 230 231 1848 1849 O
= 231 232 1849 1850 O
2 233 234 1851 1852 B-lower_bound
cm 235 237 1853 1855 I-lower_bound
) 237 238 1855 1856 O
with 239 243 1857 1861 O
conventional 244 256 1862 1874 O
techniques 257 267 1875 1885 O
or 268 270 1886 1888 O
as 271 273 1889 1891 O
> 274 275 1892 1893 O
= 275 276 1893 1894 O
10 277 279 1895 1897 B-lower_bound
mm 280 282 1898 1900 I-lower_bound
( 283 284 1901 1902 O
> 284 285 1902 1903 O
= 285 286 1903 1904 O
1 287 288 1905 1906 B-lower_bound
cm 289 291 1907 1909 I-lower_bound
) 291 292 1909 1910 O
with 293 297 1911 1915 O
spiral 298 304 1916 1922 B-treatment
computed 305 313 1923 1931 I-treatment
tomography 314 324 1932 1942 I-treatment
( 325 326 1943 1944 I-treatment
CT 326 328 1944 1946 I-treatment
) 328 329 1946 1947 I-treatment
scan 330 334 1948 1952 I-treatment
, 334 335 1952 1953 O
magnetic 336 344 1954 1962 B-treatment
resonance 345 354 1963 1972 I-treatment
imaging 355 362 1973 1980 I-treatment
( 363 364 1981 1982 I-treatment
MRI 364 367 1982 1985 I-treatment
) 367 368 1985 1986 I-treatment
, 368 369 1986 1987 O
or 370 372 1988 1990 O
calipers 373 381 1991 1999 B-treatment
by 382 384 2000 2002 O
clinical 385 393 2003 2011 O
exam 394 398 2012 2016 O

Patients 0 8 2017 2025 O
on 9 11 2026 2028 O
tacrolimus 12 22 2029 2039 B-treatment
or 23 25 2040 2042 O
any 26 29 2043 2046 O
other 30 35 2047 2052 O
immunosuppressants 36 54 2053 2071 B-treatment
with 55 59 2072 2076 O
significant 60 71 2077 2088 O
interaction 72 83 2089 2100 O
with 84 88 2101 2105 O
cisplatin 89 98 2106 2115 B-treatment

Patients 0 8 2116 2124 O
who 9 12 2125 2128 O
are 13 16 2129 2132 O
receiving 17 26 2133 2142 O
adjuvant 27 35 2143 2151 B-treatment
chemoradiation 36 50 2152 2166 I-treatment
after 51 56 2167 2172 O
surgical 57 65 2173 2181 B-treatment
resection 66 75 2182 2191 I-treatment
of 76 78 2192 2194 O
the 79 82 2195 2198 O
primary 83 90 2199 2206 O
site 91 95 2207 2211 O
of 96 98 2212 2214 O
disease 99 106 2215 2222 O

Patients 0 8 2223 2231 O
who 9 12 2232 2235 O
are 13 16 2236 2239 O
receiving 17 26 2240 2249 O
any 27 30 2250 2253 O
other 31 36 2254 2259 O
investigational 37 52 2260 2275 B-treatment
agents 53 59 2276 2282 I-treatment

Patients 0 8 2283 2291 O
who 9 12 2292 2295 O
have 13 17 2296 2300 O
had 18 21 2301 2304 O
chemotherapy 22 34 2305 2317 B-treatment
or 35 37 2318 2320 O
radiotherapy 38 50 2321 2333 B-treatment
within 51 57 2334 2340 O
4 58 59 2341 2342 O
weeks 60 65 2343 2348 O
( 66 67 2349 2350 O
6 67 68 2350 2351 O
weeks 69 74 2352 2357 O
for 75 78 2358 2361 O
nitrosoureas 79 91 2362 2374 B-treatment
or 92 94 2375 2377 O
mitomycin 95 104 2378 2387 B-treatment
C 105 106 2388 2389 I-treatment
) 106 107 2389 2390 O
prior 108 113 2391 2396 O
to 114 116 2397 2399 O
entering 117 125 2400 2408 O
the 126 129 2409 2412 O
study 130 135 2413 2418 O
or 136 138 2419 2421 O
those 139 144 2422 2427 O
who 145 148 2428 2431 O
have 149 153 2432 2436 O
not 154 157 2437 2440 O
recovered 158 167 2441 2450 O
from 168 172 2451 2455 O
adverse 173 180 2456 2463 O
events 181 187 2464 2470 O
due 188 191 2471 2474 O
to 192 194 2475 2477 O
agents 195 201 2478 2484 O
administered 202 214 2485 2497 O
more 215 219 2498 2502 O
than 220 224 2503 2507 O
4 225 226 2508 2509 O
weeks 227 232 2510 2515 O
earlier 233 240 2516 2523 O

Patients 0 8 2524 2532 O
with 9 13 2533 2537 O
known 14 19 2538 2543 O
brain 20 25 2544 2549 B-cancer
metastases 26 36 2550 2560 I-cancer
should 37 43 2561 2567 O
be 44 46 2568 2570 O
excluded 47 55 2571 2579 O
from 56 60 2580 2584 O
this 61 65 2585 2589 O
clinical 66 74 2590 2598 O
trial 75 80 2599 2604 O
because 81 88 2605 2612 O
of 89 91 2613 2615 O
their 92 97 2616 2621 O
poor 98 102 2622 2626 O
prognosis 103 112 2627 2636 O
and 113 116 2637 2640 O
because 117 124 2641 2648 O
they 125 129 2649 2653 O
often 130 135 2654 2659 O
develop 136 143 2660 2667 O
progressive 144 155 2668 2679 O
neurologic 156 166 2680 2690 O
dysfunction 167 178 2691 2702 O
that 179 183 2703 2707 O
would 184 189 2708 2713 O
confound 190 198 2714 2722 O
the 199 202 2723 2726 O
evaluation 203 213 2727 2737 O
of 214 216 2738 2740 O
neurologic 217 227 2741 2751 O
and 228 231 2752 2755 O
other 232 237 2756 2761 O
adverse 238 245 2762 2769 O
events 246 252 2770 2776 O

Patients 0 8 2777 2785 O
with 9 13 2786 2790 O
nasopharyngeal 14 28 2791 2805 B-cancer
carcinoma 29 38 2806 2815 I-cancer
, 38 39 2815 2816 O
skin 40 44 2817 2821 B-cancer
squamous 45 53 2822 2830 I-cancer
cell 54 58 2831 2835 I-cancer
carcinoma 59 68 2836 2845 I-cancer
( 69 70 2846 2847 I-cancer
SCC 70 73 2847 2850 I-cancer
) 73 74 2850 2851 I-cancer
, 74 75 2851 2852 O
and 76 79 2853 2856 O
salivary 80 88 2857 2865 B-cancer
gland 89 94 2866 2871 I-cancer
carcinomas 95 105 2872 2882 I-cancer

Platelets 0 9 2883 2892 B-clinical_variable
> 10 11 2893 2894 O
= 11 12 2894 2895 O
100,000 13 20 2896 2903 B-lower_bound
/ 20 21 2903 2904 I-lower_bound
mcL 21 24 2904 2907 I-lower_bound

Pregnant 0 8 2908 2916 B-pregnancy
women 9 14 2917 2922 B-gender
are 15 18 2923 2926 O
excluded 19 27 2927 2935 O
from 28 32 2936 2940 O
this 33 37 2941 2945 O
study 38 43 2946 2951 O
because 44 51 2952 2959 O
M6620 52 57 2960 2965 O
( 58 59 2966 2967 O
VX-970 59 65 2967 2973 O
) 65 66 2973 2974 O
as 67 69 2975 2977 O
a 70 71 2978 2979 O
DNA 72 75 2980 2983 O
- 75 76 2983 2984 O
damage 76 82 2984 2990 O
response 83 91 2991 2999 O
( 92 93 3000 3001 O
DDR 93 96 3001 3004 O
) 96 97 3004 3005 O
inhibitor 98 107 3006 3015 O
may 108 111 3016 3019 O
have 112 116 3020 3024 O
the 117 120 3025 3028 O
potential 121 130 3029 3038 O
for 131 134 3039 3042 O
teratogenic 135 146 3043 3054 B-treatment
or 147 149 3055 3057 O
abortifacient 150 163 3058 3071 O
effects 164 171 3072 3079 O

Prior 0 5 3080 3085 B-treatment
receipt 6 13 3086 3093 I-treatment
of 14 16 3094 3096 I-treatment
radiotherapy 17 29 3097 3109 I-treatment
that 30 34 3110 3114 O
would 35 40 3115 3120 O
result 41 47 3121 3127 O
in 48 50 3128 3130 O
overlap 51 58 3131 3138 O
of 59 61 3139 3141 O
the 62 65 3142 3145 O
new 66 69 3146 3149 O
and 70 73 3150 3153 O
old 74 77 3154 3157 O
radiation 78 87 3158 3167 B-treatment
therapy 88 95 3168 3175 I-treatment
fields 96 102 3176 3182 O

Prior 0 5 3183 3188 O
systemic 6 14 3189 3197 B-treatment
chemotherapy 15 27 3198 3210 I-treatment
for 28 31 3211 3214 O
the 32 35 3215 3218 O
current 36 43 3219 3226 O
cancer 44 50 3227 3233 B-cancer

Psychiatric 0 11 3234 3245 B-chronic_disease
illness 12 19 3246 3253 I-chronic_disease
/ 19 20 3253 3254 I-chronic_disease
social 20 26 3254 3260 I-chronic_disease
situations 27 37 3261 3271 I-chronic_disease
that 38 42 3272 3276 O
would 43 48 3277 3282 O
limit 49 54 3283 3288 O
compliance 55 65 3289 3299 O
with 66 70 3300 3304 O
study 71 76 3305 3310 O
requirements 77 89 3311 3323 O

Symptomatic 0 11 3324 3335 O
congestive 12 22 3336 3346 B-chronic_disease
heart 23 28 3347 3352 I-chronic_disease
failure 29 36 3353 3360 I-chronic_disease
( 37 38 3361 3362 O
requiring 38 47 3362 3371 O
hospital 48 56 3372 3380 O
stay 57 61 3381 3385 O
within 62 68 3386 3392 O
the 69 72 3393 3396 O
last 73 77 3397 3401 B-upper_bound
6 78 79 3402 3403 I-upper_bound
months 80 86 3404 3410 I-upper_bound
) 86 87 3410 3411 O

The 0 3 3412 3415 O
effects 4 11 3416 3423 O
of 12 14 3424 3426 O
M6620 15 20 3427 3432 B-treatment
( 21 22 3433 3434 I-treatment
VX-970 22 28 3434 3440 I-treatment
) 28 29 3440 3441 I-treatment
on 30 32 3442 3444 O
the 33 36 3445 3448 O
developing 37 47 3449 3459 O
human 48 53 3460 3465 O
fetus 54 59 3466 3471 O
are 60 63 3472 3475 O
unknown 64 71 3476 3483 O

Unstable 0 8 3484 3492 B-chronic_disease
angina 9 15 3493 3499 I-chronic_disease
pectoris 16 24 3500 3508 I-chronic_disease
, 24 25 3508 3509 O
cardiac 26 33 3510 3517 B-chronic_disease
arrhythmia 34 44 3518 3528 I-chronic_disease

Women 0 5 3529 3534 B-gender
of 6 8 3535 3537 O
childbearing 9 21 3538 3550 O
potential 22 31 3551 3560 O
who 32 35 3561 3564 O
are 36 39 3565 3568 O
sexually 40 48 3569 3577 O
active 49 55 3578 3584 O
should 56 62 3585 3591 O
be 63 65 3592 3594 O
willing 66 73 3595 3602 B-treatment
and 74 77 3603 3606 I-treatment
able 78 82 3607 3611 I-treatment
to 83 85 3612 3614 I-treatment
use 86 89 3615 3618 I-treatment
medically 90 99 3619 3628 I-treatment
acceptable 100 110 3629 3639 I-treatment
forms 111 116 3640 3645 I-treatment
of 117 119 3646 3648 I-treatment
contraception 120 133 3649 3662 I-treatment
throughout 134 144 3663 3673 O
the 145 148 3674 3677 O
treatment 149 158 3678 3687 B-treatment
phase 159 164 3688 3693 O
of 165 167 3694 3696 O
the 168 171 3697 3700 O
trial 172 177 3701 3706 O
and 178 181 3707 3710 O
for 182 185 3711 3714 O
up 186 188 3715 3717 O
to 189 191 3718 3720 O
6 192 193 3721 3722 B-upper_bound
months 194 200 3723 3729 I-upper_bound
following 201 210 3730 3739 I-upper_bound
the 211 214 3740 3743 O
last 215 219 3744 3748 O
administration 220 234 3749 3763 O
of 235 237 3764 3766 O
study 238 243 3767 3772 B-treatment
treatment 244 253 3773 3782 I-treatment

for 0 3 3783 3786 O
this 4 8 3787 3791 O
reason 9 15 3792 3798 O
and 16 19 3799 3802 O
because 20 27 3803 3810 O
DNA 28 31 3811 3814 O
- 31 32 3814 3815 O
damage 32 38 3815 3821 O
response 39 47 3822 3830 O
( 48 49 3831 3832 O
DDR 49 52 3832 3835 O
) 52 53 3835 3836 O
inhibitors 54 64 3837 3847 O
as 65 67 3848 3850 O
well 68 72 3851 3855 O
as 73 75 3856 3858 O
other 76 81 3859 3864 O
therapeutic 82 93 3865 3876 B-treatment
agents 94 100 3877 3883 I-treatment
used 101 105 3884 3888 O
in 106 108 3889 3891 O
this 109 113 3892 3896 O
trial 114 119 3897 3902 O
may 120 123 3903 3906 O
have 124 128 3907 3911 O
teratogenic 129 140 3912 3923 O
potential 141 150 3924 3933 O

men 0 3 3934 3937 B-gender
treated 4 11 3938 3945 O
or 12 14 3946 3948 O
enrolled 15 23 3949 3957 O
on 24 26 3958 3960 O
this 27 31 3961 3965 O
protocol 32 40 3966 3974 O
must 41 45 3975 3979 O
also 46 50 3980 3984 O
agree 51 56 3985 3990 B-contraception_consent
to 57 59 3991 3993 I-contraception_consent
use 60 63 3994 3997 I-contraception_consent
adequate 64 72 3998 4006 I-contraception_consent
contraception 73 86 4007 4020 I-contraception_consent
prior 87 92 4021 4026 O
to 93 95 4027 4029 O
the 96 99 4030 4033 O
study 100 105 4034 4039 O
, 105 106 4039 4040 O
for 107 110 4041 4044 O
the 111 114 4045 4048 O
duration 115 123 4049 4057 O
of 124 126 4058 4060 O
study 127 132 4061 4066 O
participation 133 146 4067 4080 O
, 146 147 4080 4081 O
and 148 151 4082 4085 O
for 152 155 4086 4089 O
6 156 157 4090 4091 B-upper_bound
months 158 164 4092 4098 I-upper_bound
after 165 170 4099 4104 O
completion 171 181 4105 4115 O
of 182 184 4116 4118 O
M6620 185 190 4119 4124 O
( 191 192 4125 4126 O
VX-970 192 198 4126 4132 O
) 198 199 4132 4133 O
administration 200 214 4134 4148 O

men 0 3 4149 4152 B-gender
who 4 7 4153 4156 O
are 8 11 4157 4160 O
sexually 12 20 4161 4169 O
active 21 27 4170 4176 O
must 28 32 4177 4181 O
be 33 35 4182 4184 O
willing 36 43 4185 4192 B-contraception_consent
and 44 47 4193 4196 I-contraception_consent
able 48 52 4197 4201 I-contraception_consent
to 53 55 4202 4204 I-contraception_consent
use 56 59 4205 4208 I-contraception_consent
medically 60 69 4209 4218 I-contraception_consent
acceptable 70 80 4219 4229 I-contraception_consent
forms 81 86 4230 4235 I-contraception_consent
of 87 89 4236 4238 I-contraception_consent
contraception 90 103 4239 4252 I-contraception_consent
throughout 104 114 4253 4263 O
the 115 118 4264 4267 O
treatment 119 128 4268 4277 B-treatment
phase 129 134 4278 4283 O
of 135 137 4284 4286 O
the 138 141 4287 4290 O
trial 142 147 4291 4296 O
and 148 151 4297 4300 O
for 152 155 4301 4304 O
6 156 157 4305 4306 B-upper_bound
months 158 164 4307 4313 I-upper_bound
after 165 170 4314 4319 O
completion 171 181 4320 4330 O
of 182 184 4331 4333 O
M6620 185 190 4334 4339 B-treatment
( 191 192 4340 4341 I-treatment
VX-970 192 198 4341 4347 I-treatment
) 198 199 4347 4348 I-treatment
administration 200 214 4349 4363 O

nasopharyngeal 0 14 4364 4378 B-cancer
carcinomas 15 25 4379 4389 I-cancer

patients 0 8 4390 4398 O
with 9 13 4399 4403 O
poorly 14 20 4404 4410 O
controlled 21 31 4411 4421 O
HIV 32 35 4422 4425 B-chronic_disease

prior 0 5 4426 4431 B-treatment
chemotherapy 6 18 4432 4444 I-treatment
for 19 22 4445 4448 O
a 23 24 4449 4450 O
different 25 34 4451 4460 O
cancer 35 41 4461 4467 B-cancer

women 0 5 4468 4473 B-gender
of 6 8 4474 4476 O
child 9 14 4477 4482 O
- 14 15 4482 4483 O
bearing 15 22 4483 4490 O
potential 23 32 4491 4500 O
and 33 36 4501 4504 O
men 37 40 4505 4508 O
must 41 45 4509 4513 O
agree 46 51 4514 4519 B-contraception_consent
to 52 54 4520 4522 I-contraception_consent
use 55 58 4523 4526 I-contraception_consent
adequate 59 67 4527 4535 I-contraception_consent
contraception 68 81 4536 4549 I-contraception_consent
( 82 83 4550 4551 O
hormonal 83 91 4551 4559 B-contraception_consent
or 92 94 4560 4562 I-contraception_consent
barrier 95 102 4563 4570 I-contraception_consent
method 103 109 4571 4577 I-contraception_consent
of 110 112 4578 4580 I-contraception_consent
birth 113 118 4581 4586 I-contraception_consent
control 119 126 4587 4594 I-contraception_consent

